Sa1878 – Effects of Subcutaneous Vedolizumab on Health-Related Quality of Life and Work Productivity in Patients with Ulcerative Colitis: Results from the Phase 3 Visible 1 Trial
Keyword(s):
Phase 3
◽
2017 ◽
Vol 11
(suppl_1)
◽
pp. S244-S245